0001144204-19-015666.txt : 20190322 0001144204-19-015666.hdr.sgml : 20190322 20190322184834 ACCESSION NUMBER: 0001144204-19-015666 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190315 FILED AS OF DATE: 20190322 DATE AS OF CHANGE: 20190322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CGI Cellerate RX, LLC CENTRAL INDEX KEY: 0001766396 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11808 FILM NUMBER: 19701021 BUSINESS ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 BUSINESS PHONE: 512-320-8600 MAIL ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Catalyst Rochal, LLC CENTRAL INDEX KEY: 0001766398 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11808 FILM NUMBER: 19701022 BUSINESS ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 BUSINESS PHONE: 512-320-8600 MAIL ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gurasich Bradley J. CENTRAL INDEX KEY: 0001766399 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11808 FILM NUMBER: 19701023 MAIL ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0000714256 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 592220004 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 SUMMIT AVE STREET 2: SUITE 414 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817-529-2300 MAIL ADDRESS: STREET 1: 1200 SUMMIT AVE STREET 2: SUITE 414 CITY: FORT WORTH STATE: TX ZIP: 76102 FORMER COMPANY: FORMER CONFORMED NAME: MB SOFTWARE CORP DATE OF NAME CHANGE: 19960805 FORMER COMPANY: FORMER CONFORMED NAME: INAV TRAVEL CORPORATION DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: TWISTEE TREAT CORP DATE OF NAME CHANGE: 19910220 3 1 tv516868_3.xml OWNERSHIP DOCUMENT X0206 3 2019-03-15 0 0000714256 WOUND MANAGEMENT TECHNOLOGIES, INC. WNDM 0001766396 CGI Cellerate RX, LLC 1375 ENCLAVE PARKWAY HOUSTON TX 77077 0 0 1 0 0001766398 Catalyst Rochal, LLC 1375 ENCLAVE PARKWAY HOUSTON TX 77077 0 0 1 0 0001766399 Gurasich Bradley J. 7500 RIALTO BLVD BUILDING II, SUITE 220 AUSTIN TX 78735 0 0 1 0 Series F Convertible Preferred Stock Common Stock 227363000 D 5% Convertible Promissory Note 0.09 2019-08-28 2021-03-01 Common Stock 16959339 D Reflects 1,136,815 shares of Series F Convertible Preferred Stock ("Convertible <0x200E>Preferred Stock") owned of record by CGI Cellerate RX, LLC that are immediately convertible into 237,363,000 shares of Common Stock with equivalent <0x200E>voting rights. The Convertible Preferred Stock is convertible at any time, at the holder's election and has no expiration date. CGI Cellerate RX, LLC is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virtue of these relationships, CGI Cellerate RX, LLC, Catalyst Rochal, LLC and, Mr. Gurasich may be deemed to share voting and dispositive control over the Common Stock issuable upon the conversion of the Convertible Preferred Stock. Catalyst Rochal, LLC and Mr. Gurasich disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. The Convertible Preferred Stock is convertible at on a 200 for 1 basis into fully paid and nonassessable shares of the Issuer's Common Stock. Reflects a $1,500,000.00 Convertible Promissory Note ("Note") from Wound Management Technologies, Inc. ("Issuer") to CGI Cellerate RX, LLC convertible into 16,959,339 shares of common stock of the Issuer at $0.09 per share as of December 31, 2018. CGI Cellerate RX, LLC is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virtue of these relationships, CGI Cellerate RX, LLC, Catalyst Rochal, LLC and, Mr. Gurasich may be deemed to share voting and dispositive control over the Common Stock issuable upon the conversion of the Note. Catalyst Rochal, LLC and Mr. Gurasich disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. CGI CELLERATE RX, LLC, /s/ Ron Nixon and /s/ Brad Gurasich 2019-03-21 CATALYST ROCHAL, LLC, /s/ Ron Nixon and /s/ Brad Gurasich 2019-03-21 /s/ Brad Gurasich 2019-03-21